Jun 2026 (Q2 FY26) — Aug 6, 2026
Fiserv Q2 FY26 — Guidance Cut Amid Macro Headwinds and Increased Tech Investment
Read the full callFiserv (FISV) earnings
- Jun 2026
- Jun 2026 (Q2 FY26)
- Dec 2025
Fiserv earnings: last reported Thu, 6 Aug 2026, for the quarter ended Jun 2026.
Reported
The figures, each with its period
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 5,292 | −4.1% YoY | Quarterly, as filed | Quarter to Jun 2026 | Revenue from operations as filed. |
| Operating margin | 19.2 | −11.6 pts YoY | Operating profit / revenue | Quarter to Jun 2026 | For the quarter; a change is in percentage points. |
| Net profit | 627 | −38.9% YoY | Quarterly, as filed | Quarter to Jun 2026 | Profit after tax as filed. |
Guidance
What management said, and what became of it
13 of 16 judged targets kept · 19 open · verdicts reflect calls analysed to Jun 2026.
| Target | Original wording | Said | Latest call | Verdict |
|---|---|---|---|---|
| Full-year 2026 adjusted EPS | down modestly versus 2025 (preliminary) | Sep 2025 | drive adjusted EPS to a range of $7.20 to $7.40. | Revised Down |
| Full-year 2026 adjusted effective tax rate | approximately 19% to 19.5% | Dec 2025 | For the year, we expect our adjusted effective tax rate to be approximately 19% | On Track |
3 of FISERV INC's 35 targets were missed. See which ones, and which are quietly gone. The 2 above are the free sample; 33 more targets are in the full ledger.
Claimed
- Free cash flow was strong at $1.1 billion, with a free cash flow conversion of 112% for the quarter.
- Clover GPV grew 9% on a reported basis and 11% excluding gateway conversion.
- Clover revenue grew 13% excluding anticipation and nonrecurring revenue.
- Global accounts on file grew 4% in issuing.
- Overall accounts and positions, including Finxact, grew 6% in Financial Solutions.
Qualified
- Full-year organic revenue guidance updated to a range of -1% to flat, down from previous expectations.
- Full-year adjusted operating margin guidance updated to 31% to 31.5%, reflecting a 200-250 bps reduction.
- Q2 adjusted and organic revenue decreased 4% and 5% respectively, compared to the prior year.
- Merchant Solutions adjusted operating income was down 14% to $781 million.
- Financial Solutions adjusted operating income declined 27% to $912 million.
Price
$47.21 +2.47% · +$1.14
Performance −62.0% 1Y
1Y: $124.12 on 14 Oct 2025 → $47.21. High $126.54 (27 Oct 2025), low $44.36 (2 Oct 2026).
- Previous close
- $46.07
- 52-week range
- $44.36 – $126.54
- One year
- −61.02%
Overview
- Symbol
- FISV
- Sector
- Information Technology
- Exchange
- US
- Currency
- USD
Guidance
What management said, and what became of it
13 of 16 judged targets kept · 19 open · verdicts reflect calls analysed to Jun 2026.
| Target | Original wording | Said | Latest call | Verdict |
|---|---|---|---|---|
| Full-year 2026 adjusted EPS | down modestly versus 2025 (preliminary) | Sep 2025 | drive adjusted EPS to a range of $7.20 to $7.40. | Revised Down |
| Full-year 2026 adjusted effective tax rate | approximately 19% to 19.5% | Dec 2025 | For the year, we expect our adjusted effective tax rate to be approximately 19% | On Track |
Claimed
- Free cash flow was strong at $1.1 billion, with a free cash flow conversion of 112% for the quarter.
- Clover GPV grew 9% on a reported basis and 11% excluding gateway conversion.
- Clover revenue grew 13% excluding anticipation and nonrecurring revenue.
- Global accounts on file grew 4% in issuing.
- Overall accounts and positions, including Finxact, grew 6% in Financial Solutions.
Qualified
- Full-year organic revenue guidance updated to a range of -1% to flat, down from previous expectations.
- Full-year adjusted operating margin guidance updated to 31% to 31.5%, reflecting a 200-250 bps reduction.
- Q2 adjusted and organic revenue decreased 4% and 5% respectively, compared to the prior year.
- Merchant Solutions adjusted operating income was down 14% to $781 million.
- Financial Solutions adjusted operating income declined 27% to $912 million.
The full ledger
Open FISERV INC’s full ledger
A free account opens 5 company ledgers a month. All 35 tracked commitments, with each call’s wording and source.
Call summaries
Mar 2026 (Q1 FY26) — May 5, 2026
Fiserv Q1 FY26 — Clover and Finxact Drive Growth Amidst Strategic Investments
Read the full callEvery analysed call
Fiserv earnings calls (FISV)
Financials
What the filings say
Net profit, year on year: −39% (quarter to jun 2026 against jun 2025).
| Line item | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 5,215 | 5,251 | 5,130 | 5,516 | 5,263 | 5,284 | 5,027 | 5,292 |
| Expenses | 3,613 | 3,583 | 3,735 | 3,820 | 3,827 | 3,993 | 4,109 | 4,277 |
| Operating profit | 1,602 | 1,668 | 1,395 | 1,696 | 1,436 | 1,291 | 918 | 1,015 |
| Operating margin | 30.7% | 31.8% | 27.2% | 30.8% | 27.3% | 24.4% | 18.3% | 19.2% |
| Interest | 326 | 366 | 331 | 365 | 422 | 413 | 347 | 370 |
| Profit before tax | 1,271 | 1,184 | 1,046 | 1,292 | 964 | 962 | 593 | 775 |
| Tax rate | 5.8% | 16.3% | 18.2% | 19.0% | 17.9% | 21.0% | 4.0% | 20.1% |
| Net profit | 564 | 938 | 851 | 1,026 | 792 | 811 | 571 | 627 |
| EPS ($ per share) | 0.98 | — | 1.52 | 1.86 | 1.46 | — | 1.07 | 1.18 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | 8 | 8 | 8 | 8 | 8 | — | — | — |
| Reserves | 11,635 | 12,528 | 13,441 | 14,846 | 17,376 | 20,444 | 23,575 | 27,055 |
| Total liabilities | 8,969 | 42,682 | 41,290 | 44,299 | 52,181 | 60,221 | 49,490 | 54,324 |
| Fixed assets | 398 | 1,606 | 1,628 | 1,742 | 1,958 | 2,161 | 2,374 | 3,084 |
| Total assets | 11,262 | 77,539 | 74,619 | 76,249 | 83,869 | 90,890 | 77,176 | 80,133 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | 1,552 | 2,795 | 4,147 | 4,034 | 4,618 | 5,162 | 6,631 | 6,062 |
| Cash from investing | -663 | -15,680 | -341 | -1,630 | -2,112 | -1,068 | -2,404 | -2,520 |
| Cash from financing | -842 | 14,373 | -3,431 | -1,741 | -2,478 | -4,356 | -4,165 | -3,832 |
| Net cash flow | 47 | 1,489 | 391 | 636 | -13 | -229 | 30 | -191 |
| Capital expenditure | -360 | -721 | -900 | -1,160 | -1,479 | -1,388 | -1,569 | -1,763 |
| Free cash flow | 1,192 | 2,074 | 3,247 | 2,874 | 3,139 | 3,774 | 5,062 | 4,299 |
FISV revenue by segment
| Segment | Q2 FY2024 | Q3 FY2024 | Q4 FY2024 | Q1 FY2025 | Q2 FY2025 | Q3 FY2025 | Q1 FY2026 | Q2 FY2026 | YoY growth latest quarter |
|---|---|---|---|---|---|---|---|---|---|
| Merchant | 47% | 47% | — | 46% | 48% | 49% | 47% | 49% | -1.4% |
| Financial | 47% | 46% | — | 47% | 46% | 44% | 46% | 45% | -7.7% |
Share of consolidated revenue by quarter. Q4 is the fiscal year less its first three quarters.
See how segments are shifting across companies → Segment Shift
Insider filings
58 filings between Oct 30, 2025 and Sep 17, 2026.
Open market
decisions to buy or sellPurchases
$4.45M
10 purchases by 7 insiders
Sales
None
No insider sold shares.
Compensation
not trading decisions- 30
- Award — granted as compensation
- 18
- Tax withheld — shares kept back by the company to cover tax
Who traded
open market only| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| Todd Paul M | $1.56M | — | Jun 17, 2026 |
| FRITZ LANCE M | $1.17M | — | Aug 7, 2026 |
| Rosman Adam L. | $999.9K | — | Jun 16, 2026 |
| Nixon Gordon M. | $371.8K | — | Jun 16, 2026 |
| Mamilli Wafaa | $149.7K | — | Jun 17, 2026 |
| DiSimone Harry | $101.1K | — | Jun 16, 2026 |
| Yarkoni Charlotte | $100.1K | — | Jun 16, 2026 |
Latest filings (50)
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Sep 17, 2026 | Todd Paul M Chief Financial Officer | Tax withheld | 795 | $39.2K |
| Aug 7, 2026 | FRITZ LANCE M Director | Purchase | 10,000 | $519.5K |
| Aug 3, 2026 | Rosman Adam L. Chief Admin. and Legal Officer | Award | 36,799 | $0 |
| Jun 17, 2026 | Todd Paul M Chief Financial Officer | Purchase | 10,060 | $500.0K |
| Jun 17, 2026 | Mamilli Wafaa Director | Purchase | 2,960 | $149.7K |
| Jun 16, 2026 | Nixon Gordon M. Director | Purchase | 7,500 | $371.8K |
| Jun 16, 2026 | Rosman Adam L. Chief Admin. and Legal Officer | Purchase | 10,150 | $500.7K |
| Jun 16, 2026 | DiSimone Harry Director | Purchase | 2,088 | $101.1K |
| Jun 16, 2026 | Yarkoni Charlotte Director | Purchase | 2,023 | $100.1K |
| Jun 15, 2026 | GEORGAKOPOULOS PANAGIOTIS Chief Executive Officer | Award | 50,094 | $0 |
| Jun 15, 2026 | Todd Paul M Chief Financial Officer | Award | 104,363 | $0 |
| May 21, 2026 | Shedlin Gary Director | Award | 4,121 | $0 |
| May 21, 2026 | DE CASTRO HENRIQUE Director | Award | 4,121 | $0 |
| May 21, 2026 | Nixon Gordon M. Director | Award | 5,913 | $0 |
| May 21, 2026 | Gopal Ajei Director | Award | 4,121 | $0 |
| May 21, 2026 | Dufetel Celine S Director | Award | 4,121 | $0 |
| May 21, 2026 | FRITZ LANCE M Director | Award | 4,121 | $0 |
| May 21, 2026 | Yarkoni Charlotte Director | Award | 4,121 | $0 |
| May 21, 2026 | Mamilli Wafaa Director | Award | 4,121 | $0 |
| May 21, 2026 | COHEN STEPHANIE Director | Award | 4,121 | $0 |
| May 21, 2026 | DiSimone Harry Director | Award | 4,121 | $0 |
| Feb 23, 2026 | Best Kenneth Chief Accounting Officer | Tax withheld | 531 | $31.0K |
| Feb 22, 2026 | Rosman Adam L. Chief Admin. and Legal Officer | Tax withheld | 2,202 | $135.4K |
| Feb 22, 2026 | Best Kenneth Chief Accounting Officer | Tax withheld | 802 | $49.3K |
| Feb 21, 2026 | Rosman Adam L. Chief Admin. and Legal Officer | Tax withheld | 1,455 | $89.4K |
| Feb 21, 2026 | Best Kenneth Chief Accounting Officer | Tax withheld | 642 | $39.5K |
| Feb 20, 2026 | Suryadevara Dhivya Co-President | Tax withheld | 29,594 | $1.82M |
| Feb 18, 2026 | Gelb Andrew EVP, Head of Fin. Sols. | Award | 62,094 | $0 |
| Feb 18, 2026 | Todd Paul M Chief Financial Officer | Award | 45,231 | $0 |
| Feb 18, 2026 | Rosman Adam L. Chief Admin. and Legal Officer | Award | 65,665 | $0 |
| Feb 18, 2026 | Lyons Michael P. Chief Executive Officer | Award | 309,158 | $0 |
| Feb 18, 2026 | Best Kenneth Chief Accounting Officer | Award | 15,871 | $0 |
| Feb 18, 2026 | GEORGAKOPOULOS PANAGIOTIS Co-President | Award | 182,512 | $0 |
| Feb 18, 2026 | Suryadevara Dhivya Co-President | Award | 101,572 | $0 |
| Feb 17, 2026 | GEORGAKOPOULOS PANAGIOTIS Co-President | Tax withheld | 9,212 | $584.5K |
| Feb 17, 2026 | GEORGAKOPOULOS PANAGIOTIS Co-President | Award | 18,045 | $0 |
| Feb 17, 2026 | Gelb Andrew EVP, Head of Fin. Sols. | Tax withheld | 3,486 | $221.2K |
| Feb 17, 2026 | Lyons Michael P. Chief Executive Officer | Award | 13,176 | $0 |
| Feb 17, 2026 | Gelb Andrew EVP, Head of Fin. Sols. | Award | 8,669 | $0 |
| Feb 17, 2026 | Rosman Adam L. Chief Admin. and Legal Officer | Tax withheld | 3,211 | $203.7K |
| Feb 17, 2026 | Rosman Adam L. Chief Admin. and Legal Officer | Award | 7,981 | $0 |
| Feb 17, 2026 | Lyons Michael P. Chief Executive Officer | Tax withheld | 5,620 | $356.6K |
| Feb 7, 2026 | GEORGAKOPOULOS PANAGIOTIS Co-President | Tax withheld | 4,438 | $266.3K |
| Feb 7, 2026 | Gelb Andrew EVP, Head of Fin. Sols. | Tax withheld | 1,096 | $65.8K |
| Feb 7, 2026 | Rosman Adam L. Chief Admin. and Legal Officer | Tax withheld | 1,489 | $89.3K |
| Feb 7, 2026 | Lyons Michael P. Chief Executive Officer | Tax withheld | 3,375 | $202.5K |
| Feb 7, 2026 | Best Kenneth Chief Accounting Officer | Tax withheld | 434 | $26.0K |
| Jan 17, 2026 | GEORGAKOPOULOS PANAGIOTIS Co-President | Tax withheld | 25,790 | $1.71M |
| Jan 1, 2026 | Nixon Gordon M. Director | Award | 1,743 | $0 |
| Jan 1, 2026 | Shedlin Gary Director | Award | 1,314 | $0 |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Start an Inve Case for FISERV INC
Free account. Everything above stays public.
Write why you follow FISERV INC and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading